Sign inJoin waitlistJoin the waitlist

Diana Hanna

Assistant Professor of Clinical Medicine · University of Southern California/Los Angeles General Medical Center

Credentials: · · ·

History

University of Southern California/Los Angeles General Medical Center
Present

University of Southern California/Los Angeles General Medical Center
2012–2014
Internal Medicine
University of California (Davis) Medical Center
2009–2012
University of California, Davis, School of Medicine
2005–2009

Research

Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion…
The Lancet Oncology · 2022 · 165 citations
Impact of sex on the survival of patients with hepatocellular carcinoma: a Surveillance, Epidemiology, and End Results analysis
Cancer · 2014 · 120 citations
ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016
Review · ESMO Open · 2016 · 97 citations

Heinz-Josef Lenz
22 papers
SC
Shu Cao
9 papers · 4 as a resident
Anthony El-Khoueiry
7 papers
AJ
Adham Jurdi
6 papers
AB
Afsaneh Barzi
5 papers
Gregory Botta
5 papers
AA
Alexey Aleshin
4 papers
AP
Anish Parekh
4 papers
Farshid Dayyani
4 papers
GG
Giby George
4 papers · 3 as a resident
ML
Minetta Liu
4 papers
MT
Mohamed Tejani
4 papers

Grants

University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG)
National Cancer Institute · P30
Project lead · $1.5M · University of Southern California
1996–2026

Clinical trials

Multiple Adjunct Therapies to Improve Immunotherapy Treatment in Patients With Locally Advanced or Metastatic Melanoma or Advanced Hepatocellular Cancer
Principal investigator · Not yet recruiting · Phase 2
University of Southern California
2026–2028
Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer
Principal investigator · Recruiting · Phase 1
University of Southern California
2025–2028
CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melanoma
Principal investigator · Terminated · Phase 1, Phase 2
University of Southern California
2021–2022
SW-682 in Advanced Solid Tumors
Site PI · Recruiting · Phase 1
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
2024–2027